Janux Therapeutics, Inc. - Common Stock (JANX)

CUSIP: 47103J105

Q4 2023 13F Holders as of 31 Dec 2023

Security identity
Security type / class
Equity / Common Stock
Shares outstanding
60,817,522
Holder snapshot
Total 13F shares
33,501,695
Share change
-1,610,666
Total reported value
$359,539,970
Put/Call ratio
12%
Reported price per share
$10.73
Number of holders
64
Value change
-$17,204,195
Number of buys
40
Number of sells
18

Security key

47103J105

Report period

Q4 2023

Institutions

64

Top holders

10

JANX full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2024 Previous quarter: Q3 2023 Janux Therapeutics, Inc. SEC filings Janux Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of JANX - Janux Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
RA CAPITAL MANAGEMENT, L.P.
13D/G signal
—
Evidence rows
15
Latest as of
30 Sep 2023
13F 3/4/5 Lead comparable stake: 15% Showing 1-6 of 15 holder rows.

Rank 2 holder

FMR LLC

13F
Ownership
10%
Position
$64.02M
13F

Rank 3 holder

BVF INC/IL

13F
Ownership
7.5%
Position
$46.16M
13F
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
15%
$92,389,772
9,165,652 shares
 — 30 Sep 2023
FMR LLC
13F
Company
13F
10%
$64,021,326
6,351,322 shares
 — 30 Sep 2023
BVF INC/IL
13F
Company
13F
7.5%
$46,164,565
4,579,818 shares
 — 30 Sep 2023
CITADEL ADVISORS LLC
13F
Company
13F
5.6%
$34,586,587
3,431,209 shares
 — 30 Sep 2023
ORBIMED ADVISORS LLC
13F 3/4/5
Company · Director
13F 3/4/5
5.5%
$33,444,704
3,317,927 shares
 — 30 Sep 2023
JANUS HENDERSON GROUP PLC
13F
Company
13F
3.4%
$20,823,593
2,067,468 shares
 — 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
64
Shares
33,501,695
Rows available
64
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
57
Q4 2023 holders
64
Holder diff
7
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .